Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
Prif Awdur: | Douglas, AD |
---|---|
Awduron Eraill: | Draper, SJ |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2015
|
Pynciau: |
Eitemau Tebyg
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
gan: Kapulu, MC
Cyhoeddwyd: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
gan: Forbes, E
Cyhoeddwyd: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
gan: Elias, SC
Cyhoeddwyd: (2014) -
Liver-stage vaccines for malaria
gan: Longley, RJ
Cyhoeddwyd: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
gan: Bauza, K
Cyhoeddwyd: (2012)